280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination

BACKGROUND: To cope with the SARS-CoV-2 pandemic, several treatments were studied and out of these, monoclonal antibodies (MAbs) have shown efficacy to prevent the development of pneumonia after the infection METHODS: We conducted a retrospective, single-center study including patients with SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavasio, Rosario Alessandro, Braccialarghe, Neva, Zaçe, Drieda, Spalliera, Ilaria, Coppola, Luigi, Campogiani, Laura, Piermatteo, Lorenzo, Bellocchi, Maria Concetta, Silberstein, Francesca Ceccherini, Marco, Iannetta, Sarmati, Loredana, Andreoni, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751637/
http://dx.doi.org/10.1093/ofid/ofac492.358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751637/
http://dx.doi.org/10.1093/ofid/ofac492.358

Ejemplares similares